Literature DB >> 26014466

Clinical provider perceptions of proactive medication discontinuation.

Amy Linsky1, Steven R Simon, Thomas B Marcello, Barbara Bokhour.   

Abstract

OBJECTIVES: Polypharmacy and adverse drug events lead to considerable healthcare costs and morbidity, yet there is little to guide clinical providers in the area of discontinuing medications that may not be necessary. We sought to understand providers' beliefs and attitudes about polypharmacy and medication discontinuation. STUDY
DESIGN: Qualitative study using semi-structured interviews of 20 providers with prescribing privileges at 2 US Veterans Affairs Medical Centers, from April 2012 to October 2012.
METHODS: Transcribed interviews were analyzed using grounded thematic analysis, a systematic approach to deriving qualitative themes from textual data.
RESULTS: We identified 10 themes within 4 domains of medication discontinuation. Within the first domain (medication factors), we identified 2 themes: 1) medication characteristics, and 2) uncertainties of why a patient was taking a particular drug. Within the second domain (patient factors), we identified 3 themes: 3) clinical picture of the patient, 4) clinicians' understanding of the patients' knowledge and beliefs, and 5) patients' adherence. Within the third domain (clinical provider factors), we identified 2 themes: 6) professional identity, and 7) providers' decisions related to their own beliefs about medications. Within the fourth domain (system factors), we identified 3 themes: 8) multiple providers, 9) workload, and 10) external directives and policies such as structural components of a healthcare system.
CONCLUSIONS: Provider decisions to discontinue medications are affected by factors at all levels of the clinical encounter. Our findings have implications for development and implementation of interventions to improve appropriate medication discontinuation via enhanced medication reviews, enriched patient-provider communication, and better system-level structures. This, in turn, may reduce the continued prescribing of potentially inappropriate medications that can lead to adverse outcomes or increased healthcare costs.

Entities:  

Mesh:

Year:  2015        PMID: 26014466

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  16 in total

1.  Barriers and Facilitators to the Deprescribing of Nonbenzodiazepine Sedative Medications Among Older Adults.

Authors:  Jennifer Kuntz; Louis Kouch; Daniel Christian; Preston L Peterson; Inga Gruss
Journal:  Perm J       Date:  2018

2.  Prescribers' perceptions of medication discontinuation: survey instrument development and validation.

Authors:  Amy Linsky; Steven R Simon; Kelly Stolzmann; Barbara G Bokhour; Mark Meterko
Journal:  Am J Manag Care       Date:  2016-11       Impact factor: 2.229

Review 3.  Approaches to Risk Assessment Among Older Patients With Diabetes.

Authors:  Scott J Pilla; Nancy L Schoenborn; Nisa M Maruthur; Elbert S Huang
Journal:  Curr Diab Rep       Date:  2019-07-19       Impact factor: 4.810

4.  Deprescribing in the context of multiple providers: understanding patient preferences.

Authors:  Amy Linsky; Mark Meterko; Barbara G Bokhour; Kelly Stolzmann; Steven R Simon
Journal:  Am J Manag Care       Date:  2019-04       Impact factor: 2.229

5.  Advancing the Science of Deprescribing: A Novel Comprehensive Conceptual Framework.

Authors:  Amy Linsky; Walid F Gellad; Jeffrey A Linder; Mark W Friedberg
Journal:  J Am Geriatr Soc       Date:  2019-08-20       Impact factor: 5.562

6.  Prescriptions for Potentially Inappropriate Medications from the Beers Criteria Among Older Adults Hospitalized for Heart Failure.

Authors:  Diana Jaber; Fabian Vargas; Linh Nguyen; Joanna Ringel; Kate Zarzuela; Mahad Musse; Min Ji Kwak; Emily B Levitan; Mathew S Maurer; Mark S Lachs; Monika M Safford; Parag Goyal
Journal:  J Card Fail       Date:  2021-11-21       Impact factor: 6.592

Review 7.  Antimuscarinic Anticholinergic Medications in Parkinson Disease: To Prescribe or Deprescribe?

Authors:  Matthew J Barrett; Lana Sargent; Huma Nawaz; Daniel Weintraub; Elvin T Price; Allison W Willis
Journal:  Mov Disord Clin Pract       Date:  2021-10-08

8.  Factors Associated With Potentially Inappropriate Phosphodiesterase-5 Inhibitor Use for Pulmonary Hypertension in the United States, 2006 to 2015.

Authors:  Kari R Gillmeyer; Seppo T Rinne; Mark E Glickman; Kyung Min Lee; Qing Shao; Shirley X Qian; Elizabeth S Klings; Bradley A Maron; Joseph T Hanlon; Donald R Miller; Renda Soylemez Wiener
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-05-12

9.  Physician Perspectives on Deprescribing Cardiovascular Medications for Older Adults.

Authors:  Parag Goyal; Timothy S Anderson; Gwen M Bernacki; Zachary A Marcum; Ariela R Orkaby; Dae Kim; Andrew Zullo; Ashok Krishnaswami; Arlene Weissman; Michael A Steinman; Michael W Rich
Journal:  J Am Geriatr Soc       Date:  2019-09-11       Impact factor: 5.562

10.  Supporting medication discontinuation: provider preferences for interventions to facilitate deprescribing.

Authors:  Amy Linsky; Mark Meterko; Kelly Stolzmann; Steven R Simon
Journal:  BMC Health Serv Res       Date:  2017-06-28       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.